Co-Diagnostics, Inc.
شراء
تم تحديثه

CODX Bullish Setup

438
CODX has now gained great bullish momentum for a breakout to the following targets. The Butterfly pattern is also indicating a new bullish trend to TP3 can take place.
ملاحظة
لقطة
أغلقت الصفقة: تم الوصول لوقف الخسارة
ملاحظة
Second Quarter 2022 Financial Results:

Revenue of $5.0 million, down from $27.4 million during the prior year period, due primarily to lower demand of the Logix Smart™ COVID-19 Test

Gross profit of $4.1 million, representing 81.8% of consolidated revenue stemming from inefficiencies in lower sales volumes

Operating loss of $4.1 million compared to operating income of $11.8 million a year ago, due to lower sales volumes and continued investments into research and development

Net loss of $2.7 million, compared to a net income of $9.8 million in the prior-year second quarter, representing a loss of $0.08 per fully diluted share

Adjusted EBITDA loss of $2.3 million

إخلاء المسؤولية

لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.